The DSMZ welcomes new cell lines for accession. Expansion, quality control, characterization and distribution of cell lines are costly. Hence, evidence of utility and the likelihood of demand for each new cell line is necessary to justify accessioning. The DSMZ Cell Lines Bank accessions only continuous cell lines (including hybridomas) which have been published or are in the process of publication.
Please click here for futher information.